Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1259/bjr.20140206 http://scihub22266oqcxt.onion/10.1259/bjr.20140206 C4453151!4453151!25007037     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534       Br+J+Radiol 2014 ; 87 (1041): ä Nephropedia Template TP {{tp|p=25007037|t=2014. In vivo dosimetry: trends and prospects for brachytherapy |pdf=|usr=}}{{25007037}} gab.com Text In vivo dosimetry: trends and prospects for brachytherapy JO: Br J Radiol http://www.kidney.de/pget.php?&tw=1&pmid=25007037 #FOAvip The error types during brachytherapy (BT) treatments and their occurrence rates are not well known. The limited knowledge is partly attributed to the lack of independent verification systems of the treatment progression in the clinical workflow routine. Within the field of in vivo dosimetry (IVD), it is established that real-time IVD can provide efficient error detection and treatment verification. However, it is also recognized that widespread implementations are hampered by the lack of available high-accuracy IVD systems that are straightforward for the clinical staff to use. This article highlights the capabilities of the state-of-the-art IVD technology in the context of error detection and quality assurance (QA) and discusses related prospects of the latest developments within the field. The article emphasizes the main challenges responsible for the limited practice of IVD and provides descriptions on how they can be overcome. Finally, the article suggests a framework for collaborations between BT clinics that implemented IVD on a routine basis and postulates that such collaborations could improve BT QA measures and the knowledge about BT error types and their occurrence rates. Twit Text FOAVip In vivo dosimetry: trends and prospects for brachytherapy ????Br J Radiol http://www.kidney.de/pget.php?&tw=1&pmid=25007037 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25007037 #FOAvip English Wikipedia <ref>{{Cite pmid|25007037}}</ref> In vivo dosimetry: trends and prospects for brachytherapy #MMPMID25007037 Kertzscher G; Rosenfeld A; Beddar S; Tanderup K; Cygler JE Br J Radiol 2014[Sep]; 87 (1041): ä PMID25007037show ga The error types during brachytherapy (BT) treatments and their occurrence rates are not well known. The limited knowledge is partly attributed to the lack of independent verification systems of the treatment progression in the clinical workflow routine. Within the field of in vivo dosimetry (IVD), it is established that real-time IVD can provide efficient error detection and treatment verification. However, it is also recognized that widespread implementations are hampered by the lack of available high-accuracy IVD systems that are straightforward for the clinical staff to use. This article highlights the capabilities of the state-of-the-art IVD technology in the context of error detection and quality assurance (QA) and discusses related prospects of the latest developments within the field. The article emphasizes the main challenges responsible for the limited practice of IVD and provides descriptions on how they can be overcome. Finally, the article suggests a framework for collaborations between BT clinics that implemented IVD on a routine basis and postulates that such collaborations could improve BT QA measures and the knowledge about BT error types and their occurrence rates. äIn vivo dosimetry: trends and prospects for brachytherapy (epmc).pdf DeepDyve Pubget Overpricing